Ischemic retinal vein occlusion: Characterizing the more severe spectrum of retinal vein occlusion

视网膜静脉 医学 闭塞 视网膜中央静脉阻塞 黄斑水肿 视网膜分支静脉阻塞 静脉 视网膜 眼科 心脏病学 内科学
作者
Meiaad Khayat,Michael Williams,Noemi Lois
出处
期刊:Survey of Ophthalmology [Elsevier BV]
卷期号:64 (3): 440-441 被引量:77
标识
DOI:10.1016/j.survophthal.2019.01.006
摘要

Retinal vein occlusion (RVO)-including central RVO, branch RVO, and hemicentral and hemispheric RVO—is the second most common vascular cause of visual loss, surpassed only by diabetic retinopathy. The presence and extent of retinal ischemia in RVO is associated with a worse prognosis. On this basis, most previously conducted studies considered ischemic retinal vein occlusion (iRVO) and non-iRVO as separate entities based on set thresholds of existing retinal ischemia as determined by fundus fluorescein angiography. Other diagnostic technologies have been used specifically in the differentiation of ischemic central retinal vein occlusion and nonischemic central retinal vein occlusion. To date, there is no fully accepted definition for iRVO. Some clinicians and researchers may favor establishing a clear differentiation between these forms of RVO; others may prefer not to consider iRVO as a separate entity. Whatever the case, retinal ischemia in RVO confers a higher risk of visual loss and neovascular complications; thus, it should be determined as accurately as possible in patients with this disease and be considered in clinical and experimental studies. Most recently conducted clinical trials evaluating new treatments for macular edema secondary to RVO included none or only few patients with iRVO based on previous definitions (i.e., few patients with sizeable areas of retinal ischemia were recruited in these trials), and thus it is unclear whether the results observed in recruited patients could be extrapolated to those with retinal ischemia. There has been scant research aiming at developing and/or testing treatments for retinal ischemia, as well as to prevent new vessel formation as a result of RVO. We provide a detailed review of the knowledge gathered over the years on iRVO, from controversies on its definition and diagnosis to the understanding of its epidemiology, risk factors and pathogenesis, the structural and functional effects of this disease in the eye and its complications, natural history, and outcomes after treatment. In each section, the definition of iRVO used is given so, independently of whether iRVO is considered a separate clinical entity or a more severe end of the spectrum of RVO, the information will be useful to clinicians to determine patient's risk, guide therapeutic decisions, and counsel patients and for researchers to design future studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
小豆包完成签到,获得积分10
2秒前
Bloo完成签到,获得积分10
2秒前
lyq完成签到,获得积分10
3秒前
拾柒完成签到 ,获得积分10
3秒前
4秒前
4秒前
不能没有科研完成签到,获得积分10
7秒前
荣荣发布了新的文献求助10
7秒前
7秒前
十二完成签到,获得积分10
8秒前
8秒前
小杨肉串完成签到,获得积分10
8秒前
十八完成签到,获得积分10
9秒前
Jasper的应助被shgong采纳,获得10
9秒前
10秒前
我是老大的应助被大头采纳,获得10
10秒前
hqlran完成签到,获得积分10
11秒前
玄魁完成签到,获得积分10
11秒前
12秒前
魔幻飞风发布了新的文献求助10
12秒前
科学家完成签到,获得积分10
13秒前
柠檬水完成签到,获得积分10
13秒前
天天向上的应助被小小昌采纳,获得10
14秒前
14秒前
yuyuhong完成签到,获得积分10
15秒前
Jade完成签到 ,获得积分10
16秒前
qiao完成签到,获得积分10
17秒前
砥砺前行发布了新的文献求助10
17秒前
18秒前
Jasper的应助被successful采纳,获得10
19秒前
初景的应助被小川采纳,获得20
19秒前
淡然的大雁完成签到,获得积分10
19秒前
搜集达人的应助被木棉花糖采纳,获得10
19秒前
Sieg完成签到 ,获得积分10
19秒前
wpan完成签到,获得积分20
20秒前
Frank完成签到 ,获得积分10
20秒前
Sean完成签到,获得积分10
20秒前
疯狂的千凡完成签到 ,获得积分20
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181823
求助须知:如何正确求助?哪些是违规求助? 9571511
关于积分的说明 21818391
捐赠科研通 7778076
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479614